Patients' and doctors' preferences for adjuvant chemotherapy in resected non-small-cell lung cancer: What makes it worthwhile?

P. Blinman, B. Hughes, C. Crombie, T. Christmas, M. Hudson, A.S. Veillard, N. Muljadi, Michael Millward, G. Wright, P. Flynn, M. Windsor, M. Stockler, S.A. Mclachlan

    Research output: Contribution to journalArticlepeer-review

    16 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Patients' and doctors' preferences for adjuvant chemotherapy in resected non-small-cell lung cancer: What makes it worthwhile?'. Together they form a unique fingerprint.

    Medicine and Dentistry

    Nursing and Health Professions

    Psychology

    Social Sciences